What is PDS Biotechnology Corp?
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 107.07M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.